Hirohito Hasegawa
Overview
Explore the profile of Hirohito Hasegawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goto S, Komaba H, Moriwaki K, Fujimori A, Shibuya K, Nishioka M, et al.
Clin J Am Soc Nephrol
. 2011 May;
6(6):1375-84.
PMID: 21551021
Background And Objectives: Lanthanum carbonate (LC) is a nonaluminum, noncalcium phosphate binder that is effective for hyperphosphatemia in dialysis patients. However, its efficacy and cost-effectiveness as second-line therapy have not...
2.
Takeda Y, Komaba H, Goto S, Fujii H, Umezu M, Hasegawa H, et al.
Am J Nephrol
. 2011 Apr;
33(5):421-6.
PMID: 21502756
Background/aims: Fibroblast growth factor-23 (FGF23) plays a central role in the development of hypophosphatemia and inappropriately low 1,25-dihydroxyvitamin D induced by iron therapy for iron-deficiency anemia. The aim of this...
3.
Komaba H, Nakanishi S, Fujimori A, Tanaka M, Shin J, Shibuya K, et al.
Clin J Am Soc Nephrol
. 2010 Aug;
5(12):2305-14.
PMID: 20798251
Background And Objectives: Cinacalcet is effective in reducing serum parathyroid hormone (PTH) in patients with secondary hyperparathyroidism. However, it has not been proven whether parathyroid gland size predicts response to...
4.
Taniguchi H, Sakagami J, Suzuki N, Hasegawa H, Shinoda M, Tosa M, et al.
Int J Clin Oncol
. 2009 Apr;
14(2):167-70.
PMID: 19390950
We present the case of a 62-year-old Japanese man whose histological diagnosis was adenoendocrine cell carcinoma of the gallbladder at autopsy, but whose antemortem diagnosis was squamous cell carcinoma. The...
5.
Abe T, Kobata H, Hanba Y, Kitabata Y, Narukawa N, Hasegawa H, et al.
Ther Apher Dial
. 2004 May;
8(3):180-4.
PMID: 15154867
Plasma exchange (PE) is often performed in combination with hemodialysis (HD) or hemodiafiltration. However, most methods were developed for the treatment of renal failure, so various problems may arise during...
6.
Abe T, Uchita K, Orita H, Kamimura M, Oda M, Hasegawa H, et al.
Kidney Int
. 2003 Sep;
64(4):1522-8.
PMID: 12969174
Background: beta2-microglobulin (beta2-m) is considered a major pathogenic factor in dialysis-related amyloidosis (DRA), often seen in long-term dialysis patients. No effective therapy for this severely debilitating disease is currently available....